8 completed, 7 recruiting, 3 not yet recruiting, 3 unknown. 4 Phase 2, 3 Phase 1, 2 Not applicable, 2 Phase 3, 1 Early Phase 1.
Follow ANCA-associated Vasculitis: new trials by email Literature Review of ANCA-associated Vasculitis trials Research Report on ANCA-associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research Pericarditis, Tako-TSUBO Cardiomyopathy | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 300 | 2026-09-01 | 2026-08-10 | |
| Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies blood draw - Systemic Lupus Erythematosus, Systemic Scleroderma | Recruiting | University Hospital, Strasbourg, France | 200 | 2026-01-20 | 2026-08-20 | |
| (68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis ANCA-associated Vasculitis | Recruiting | Ruijin Hospital | 30 | 2025-09-01 | 2025-11-17 | |
| Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV RD06-04 Cell Injection Infusion - Idiopathic Inflammatory Myopathies, ANCA-Associated Vasculitis | Early Phase 1 | Not yet recruiting | Peking University People's Hospital | 12 | 2025-06-14 | 2025-05-22 |
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases universal allogeneic anti-CD19/BCMA CAR T-cells - Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia | Phase 1 | Not yet recruiting | Changzhou No.2 People's Hospital | 18 | 2025-05-01 | 2025-05-18 |
| BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases BCMA-CD19 CAR-T therapy - Systemic Lupus Erythematosus, Inflammatory Myopathy | Phase 2 | Recruiting | Peking University People's Hospital | 50 | 2024-12-26 | 2025-04-02 |
| The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases FKC289 - Lupus Nephritis, ANCA-associated Vasculitis | Phase 1 | Recruiting | Nanjing University School of Medicine | 24 | 2024-03-04 | 2026-07-06 |
| Avacostar - (PASS) ANCA-associated Vasculitis | Active not recruiting | Vifor Fresenius Medical Care Renal Pharma | 507 | 2023-09-11 | 2026-07-24 | |
| Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM) Azathioprine, Telitacicept - ANCA-associated Vasculitis, Maintenance Therapy | Phase 4 | Recruiting | Chinese SLE Treatment And Research Group | 40 | 2023-03-09 | 2023-07-28 |
| Biocollection of Patients With ANCA Associated Vasculitis Blood samples (80 mL), Fecal samples, Urinary sample (20-40 mL) - ANCA-associated Vasculitis | Not applicable | Recruiting | University Hospital, Brest | 100 | 2022-10-27 | 2026-06-25 |
| Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis BDB-001 injection, Cyclophosphamide, Glucocorticoids - ANCA-associated Vasculitis | Phase 1 / Phase 2 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 93 | 2022-02-22 | 2025-08-07 |
| Pediatric ANCA Associated-vasculitis ANCA-Associated Vasculitis | Unknown | University Hospital, Strasbourg, France | 500 | 2022-01-01 | 2022-05-20 | |
| Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator ANCA-associated Vasculitis, Granulomatosis With Polyangiitis | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 201 | 2021-06-15 | 2025-12-02 | |
| PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis vitamin D - ANCA-associated Vasculitis, Granulomatosis With Polyangiitis | Not applicable | Completed | Christian Pagnoux | 102 | 2020-08-01 | 2023-03-14 |
| MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS Non interventional study - ANCA-associated Vasculitis | Completed | Nantes University Hospital | 63 | 2017-08-28 | 2020-10-22 | |
| A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Avacopan, Prednisone, Cyclophosphamide - ANCA-Associated Vasculitis | Phase 3 | Completed | Amgen | 331 | 2017-03-15 | 2025-03-24 |
| Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis Pneumococcal Infection, ANCA-associated Vasculitis | Completed | Assistance Publique - Hôpitaux de Paris | 19 | 2015-09-01 | 2016-08-19 | |
| Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis Pneumococcal Infection, ANCA-associated Vasculitis | Unknown | Assistance Publique - Hôpitaux de Paris | 30 | 2015-06-01 | 2016-02-25 | |
| Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Abatacept, placebo - Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis | Phase 3 | Completed | University of South Florida | 65 | 2015-04-25 | 2024-07-29 |
| Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis CCX168 10 mg, twice daily, plus cyclophosphamide/rituximab plus glucocorticoids, CCX168 30 mg, twice daily, cyclophosphamide/rituximab plus glucocorticoids, Placebo, twice daily, plus cyclophosphamide/rituximab plus glucocorticoids - ANCA-associated Vasculitis | Phase 2 | Completed | Amgen | 42 | 2015-02-04 | 2025-03-13 |
Showing 20 of 24. Sign in to see all of them.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (24) · Granulomatosis with Polyangiitis (5) · Vasculitis (5) · Microscopic Polyangiitis (4) · Myositis (4) · Scleroderma, Systemic (4) · Antiphospholipid Syndrome (3) · Immunoglobulin G4-Related Disease (3) · Lupus Erythematosus, Systemic (3) · Systemic Vasculitis (3) · Behcet Syndrome (2) · Churg-Strauss Syndrome (2) · Giant Cell Arteritis (2) · Pneumococcal Infections (2) · Takayasu Arteritis (2)
Autoimmune Diseases (24) · Cardiovascular Diseases (24) · Immune System Diseases (24) · Skin Diseases (24) · Skin Diseases, Vascular (24) · Skin and Connective Tissue Diseases (24) · Vascular Diseases (23) · Systemic Vasculitis (21) · Vasculitis (19) · Nervous System Diseases (9) · Brain Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Connective Tissue Diseases (6) · Lung Diseases, Interstitial (5)
Cyclophosphamide (3) · Abatacept (2) · Azathioprine (2) · Blood Specimen Collection (2) · Glucocorticoids (2) · Prednisone (2) · Rituximab (2) · avacopan (2) · BDB001 (1) · Phlebotomy (1) · Surveys and Questionnaires (1) · Vitamin D (1) · telitacicept (1)
Assistance Publique - Hôpitaux de Paris (3) · Amgen (2) · Peking University People's Hospital (2) · University Hospital, Strasbourg, France (2) · Changzhou No.2 People's Hospital (1) · Chinese SLE Treatment And Research Group (1) · Christian Pagnoux (1) · Imperial College London (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Nanjing University School of Medicine (1) · Nantes University Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Peking Union Medical College Hospital (1) · Ruijin Hospital (1)
China (8) · France (7) · Canada (5) · United Kingdom (5) · United States (4) · Germany (3) · Ireland (2) · Australia (1) · Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · Hungary (1) · Italy (1) · Japan (1)
Matthieu Groh, MD, MSc (2) · Alan Salama (1) · Alan Salama, MD (1) · Arielle Mendel, MD MSc (1) · Carol A Langford, MD, MHS (1) · Christian Pagnoux, MD (1) · Fadi Fakhouri, Pr (1) · JIng Li, M.D. (1) · Jeffrey P Krischer, PhD (1) · Juhong Shi, M.D (1) · Minghui Zhao, Postdoc (1) · Peter A Merkel, MD, MPH (1) · Peter C Grayson, M.D. (1) · Zhanguo Li (1)
PMID 31649025, PMID 31785185, PMID 32088663, PMID 33128347, PMID 33367837, PMID 33544969, PMID 33596356, PMID 35167187, PMID 37979959, PMID 41052893, PMID 41875213
U54AR057319 (1)